Activity Details

Free CME
0.75 AMA PRA Category 1 Credit(s)
Released: December 7, 2018
Expires: December 6, 2019
45 minutes

Accredited By

Target Audience

Pediatric neurologists, neurologists, neuromuscular specialists, pediatricians

Learning Objectives

  • Review new information on the management of patients with SMA released at the Child Neurology Society and World Muscle Society 2018 annual meetings
  • Apply new information to current SMA management practices, as relevant

Activity Description

This education provides the opportunity to learn the latest in the management of patients with Type 1 or Type 3 spinal muscular atrophy (SMA). Abstracts of posters from recent neurology meetings are presented followed by video discussions by expert faculty regarding the implication on the management of patients. Skills can then be applied in an interactive case where the learner is challenged to make decisions for a patient with Type 1 or Type 3 SMA. 

Statement of Educational Need

The recent, rapid influx of information surrounding approved and emerging treatments for spinal muscular atrophy (SMA) has created a gap in clinician knowledge and the ability to apply it to practice.


Type 1 SMA abstracts
NURTURE Update in Presymptomatic Patients (3:35)
Dr. Nancy Kuntz and Dr. Richard Finkel
Improvement for Patients in ENDEAR Study (4:07)
Dr. Nancy Kuntz and Dr. Richard Finkel
Type 1 interactive case

Type 3 SMA abstracts
Results in Type 3 Patients Treated with Nusinersen (3:05)
Dr. Richard Finkel, Dr. Nancy Kuntz, and Dr. Gyula Acsadi
A Multidisciplinary Team is Essential to the Management of SMA (2:08)
Dr. Thomas Crawford and Dr. Laurent Servais
Type 3 interactive case


Gyula Acsadi, MD, PhD
Division Head of Neurology and Rehabilitation
Professor of Pediatric Neurology
Connecticut Children’s Medical Center
University of Connecticut Medical School
Farmington, Connecticut

  • Dr. Gyula Acsadi serves as a consultant for AveXis, Biogen, and Sarepta. He is on the speakers bureau for Biogen and conducts contract research for Biogen, Italfarmaco, and Sarepta.

Thomas Crawford, MD
Co-Director, Muscular Dystrophy Association Clinic
Professor of Neurology
Johns Hopkins Medicine
Baltimore, Maryland

  • Dr. Crawford serves as a consultant and is on the advisory boards for AveXis, Inc., Biogen, Mallinckrodt, Marathon, Roche/Genentech, Santhera, and Scholar Rock.

Richard S. Finkel, MD
Division Chief of Neurology
Pediatric Neurology
Nemours Children’s Hospital
Orlando, Florida

  • Dr. Richard Finkel is a consultant for AveXis, Biogen, Catabasis, Ionis, Mitobridge, Roche, and Novartis. He receives clinical trial support from AveXis, Biogen, Ionis, Catabasis, Cytokinetics, Lilly, MDA, NIH, ReveraGen, and Summit. Dr. Finkel owns stock in Roche. His partner holds several patents and receives patent licensing royalties from National Jewish Center and Children’s Hospital of Philadelphia.

Nancy L. Kuntz, MD
Professor of Pediatrics and Neurology
Northwestern University Feinberg School of Medicine
Attending Physician
Division of Neurology
Ann & Robert H. Lurie Children’s Hospital of Chicago
Chicago, Illinois

  • Dr. Kuntz serves on clinical advisory boards for Audentes, AveXis, Inc., Biogen, Roche, and Sarepta. She has participated in educational lectures funded by Biogen.

Laurent Servais, MD, PhD
Pediatric Neurology
Institut de Myologie
Paris, France

  • Dr. Servais serves on advisory boards for AveXis, Inc., Biogen, and Roche. He is a principle investigator for projects funded by AveXis, Inc., Biogen, and Roche.

Conflict of Interest Policy/Disclosure Statement

Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, The France Foundation (TFF) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. Furthermore, TFF seeks to verify that all scientific research referred to, reported, or used in a CME/CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF is committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of a commercial interest.

Activity Staff Disclosures
The planners, reviewers, editors, staff, CME committee, or other members at The France Foundation who control content have no relevant financial relationships to disclose.

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The France Foundation designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.

Instructions for Receiving Credit

  • There are no fees for participating in and receiving credit for this activity.
  • Review the activity objectives and CME/CE information.
  • Complete the CME/CE activity
  • Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  • Complete the CME/CE evaluation/attestation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  • Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credit(s)™ or a certificate of participation—your CME/CE certificate will be available for download.

Statement of Commercial Support

This activity is supported by an educational grant from Biogen.


The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Disclosure of Unlabeled Use

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Contact Information

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or

Hardware/Software Requirements

Pro-CME recommends using the latest versions of these supported browsers: Google Chrome, Microsoft Internet Explorer, Mozilla Firefox, Safari. Depending on your browser of choice, additional software, such as Adobe Reader® and Adobe® Flash® Player may be required.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.